Location: Home
  • search
  • go
  • Relate News
  • 9/20/2024China to Raise Retirement Age to 63 Amid Growing Pressure from Aging P...
  • 9/19/2024Celregen Thera Secures CNY Multi-Millions in Angel Round Financing
  • 9/19/2024CDE Issues the Technical Guidelines for Clinical Trials of Cardiac Arr...
  • 9/19/2024CDE Issues the Technical Guidelines for Clinical Design of Denosumab I...
  • 9/19/2024Kite Sells Stake in Fosun JV, Giving Chinese Partner Full Control of C...
  • 9/19/2024Kenvue Targets Innovation to Capitalize on China's Expanding Consumer ...
  • 9/19/2024China's Implementation of Patent Term Adjustment (SM)
  • 9/18/2024China to Accelerate Approval of Innovative Drugs and Medical Devices, ...
  • 9/17/2024NHSA Announces Conclusion of Expert Evaluation for 2024 DRDL Inclusion...
  • 9/17/2024NHC's Annual Statistical Report on China Healthcare Sector Development...
  • 9/17/2024Biopharma Prepares to Pivot from China as Biosecure Act Advances (Phar...
  • 9/13/2024Fosun Pharma to Acquire Full Ownership of Fosun Kite and Strengthens P...
  • 9/13/2024CDE Issues the Pilot Work Plan for Patient-Centered Rare Disease Drug ...
  • 9/13/2024NHSA and MOF Jointly Issue Reform Policies Relatinng to Direct Settlem...
  • 9/13/2024Organon Enters into China Licensing Deal for Fertility Asset with Bao ...
  • 9/13/2024China Courts Global Pharma with Promises of Faster Drug Approvals and ...
  • 9/13/2024China Reports Increase in Innovative Drug Approvals
  • 9/13/2024IQVIA: Chinese Hospital Drug Market Down 0.2% in MAT Q2/2024
  • 9/13/2024IQVIA: Chinese Retail Pharmacy Sales Down 1.2% in H1/2024
  • 9/13/2024Recent Official and Executive Moves
  • 9/12/2024Allergan Aesthetics Launches BOTOX Cosmetic for MMP in China
  • 9/12/2024GenAssist Dosed the First DMD Clinical Base Editing Drug
  • 9/12/2024CDE Solicits Comments on Draft of the Implementation Suggestions and C...
  • 9/12/2024Innovent's Mazdutide Outperforms Trulicity in Phase III Type 2 Diabete...
  • 9/12/2024China Dispatches More Urban Medical Personnel to Strengthen Grassroot...
  • 9/12/2024Equity Investment + Licensing: The NewCo Model Paves a New Path for Ch...
  • 9/12/2024China Biopharma Tracker – August 2024 (PharmaDJ)
  • 9/11/2024China Boosts Regulatory Framework for Local Pharmaceutical Manufacturi...
  • 9/11/2024NewCo Model Gains Traction among Chinese Biotechs (ThePharmaLetter)
  • 9/11/2024China to Implement Comprehensive Measures to Enhance Insurance Sector ...
  • Page:49/774 Total number of articles:23207: [First][<<] [47] [48] [49] [50] [51] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group